NASDAQ:BMGL Basel Medical Group (BMGL) Stock Price, News & Analysis $0.62 +0.02 (+3.89%) Closing price 04:00 PM EasternExtended Trading$0.61 -0.01 (-1.47%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Basel Medical Group Stock (NASDAQ:BMGL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Basel Medical Group alerts:Sign Up Key Stats Today's Range$0.54▼$0.6250-Day Range$0.49▼$0.7652-Week Range$0.38▼$4.55Volume105,234 shsAverage Volume1.76 million shsMarket Capitalization$11.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore. Read More Basel Medical Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks20th Percentile Overall ScoreBMGL MarketRank™: Basel Medical Group scored higher than 20% of companies evaluated by MarketBeat, and ranked 776th out of 852 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingBasel Medical Group has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageBasel Medical Group has only been the subject of 1 research reports in the past 90 days.Read more about Basel Medical Group's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioBasel Medical Group has a P/B Ratio of 3.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.09% of the float of Basel Medical Group has been sold short.Short Interest Ratio / Days to CoverBasel Medical Group has a short interest ratio ("days to cover") of 1.48, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Basel Medical Group has recently decreased by 31.54%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBasel Medical Group does not currently pay a dividend.Dividend GrowthBasel Medical Group does not have a long track record of dividend growth. News and Social Media2.5 / 5News Sentiment-0.01 News SentimentBasel Medical Group has a news sentiment score of -0.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Basel Medical Group this week, compared to 1 article on an average week.Search Interest1 people have searched for BMGL on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Basel Medical Group to their MarketBeat watchlist in the last 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Basel Medical Group insiders have not sold or bought any company stock.Percentage Held by InstitutionsBasel Medical Group has minimal institutional ownership at this time.Read more about Basel Medical Group's insider trading history. Receive BMGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Basel Medical Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BMGL Stock News HeadlinesBasel Medical Group (NASDAQ:BMGL) Shares Set to Reverse Split on Monday, June 22ndJune 14, 2026 | americanbankingnews.comBasel Medical Group Ltd: BMGL to Effect Reverse Share Split on June 22, 2026June 10, 2026 | finanznachrichten.deThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst environment in 50 years - with portfolios potentially staying in the red for 10 years or longer. From rate spikes in 2022 to $12 trillion wiped out in 30 days during the Iran War, Wall Street suggests the volatility isn't slowing down. TradeSmith CEO Keith Kaplan is showing investors what steps to take now to prepare their wealth before this worsens.June 18 at 1:00 AM | TradeSmith (Ad)Why Did BMGL Stock Slump 18% Today?June 10, 2026 | msn.comQingSong Health Corp (2661.HK) and Basel Medical Sign Strategic Cooperation Memorandum to Explore AI Healthcare Services in Southeast AsiaJune 10, 2026 | prnewswire.comBasel Medical Group to Execute 1-for-12 Reverse Share Split to Maintain Nasdaq ListingJune 10, 2026 | tipranks.comBMGL to Effect Reverse Share Split on June 22, 2026June 10, 2026 | globenewswire.comBasel Medical Group Ltd Ordinary Shares (BMGL) SEC FilingsJune 5, 2026 | nasdaq.comSee More Headlines BMGL Stock Analysis - Frequently Asked Questions How have BMGL shares performed this year? Basel Medical Group's stock was trading at $0.49 at the beginning of the year. Since then, BMGL stock has increased by 25.9% and is now trading at $0.6171. When did Basel Medical Group's stock split? Basel Medical Group's stock reverse split on the morning of Monday, June 22nd 2026.A 1-12 reverse split was announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, June 21st 2026. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. When did Basel Medical Group IPO? Basel Medical Group (BMGL) raised $10 million in an initial public offering (IPO) on Tuesday, February 25th 2025. The company issued 2,205,000 shares at $4.00-$5.00 per share. How do I buy shares of Basel Medical Group? Shares of BMGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today6/18/2026Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:BMGL CIK2004489 WebN/A Phone(656) 291-9188FaxN/AEmployees36Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$8.90 million Price / Sales1.30 Cash FlowN/A Price / Cash FlowN/A Book Value$0.20 per share Price / Book3.09Miscellaneous Outstanding Shares18,790,000Free FloatN/AMarket Cap$11.60 million OptionableN/A Beta0.19 10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free Report This page (NASDAQ:BMGL) was last updated on 6/18/2026 by MarketBeat.com Staff. From Our PartnersThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredHopeless About Retirement? Hopeless and Helpless Aren’t the Same ThingYour retirement date didn't move once - it moved slowly, then repeatedly, until the shift felt normal. That's ...Golden Portfolio | SponsoredDo NOT buy or sell SPCX before reading thisSpaceX may be the biggest IPO in history, but according to Joel Litman - who called AMD before it rose as much...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredTesla's robot factory goes live this summerOn Tesla's Q1 2026 earnings call, Elon Musk confirmed Optimus robot production at the Fremont factory begins l...StocksToTrade | SponsoredA 3M Oz. Historical Gold Resource And A Market That Hasn't Caught UpOne Canadian junior explorer controls a gold and copper system in British Columbia's Kootenay Golden Arc - a d...Wall Street Logic | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basel Medical Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Basel Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
